Riskpilot← Back to searchSign inGet full accessBiol Aktiebolag
ABActiveOrg 5562663053Skogsslingan 26Research and experimental development on natural sciences and engineering · NACE 7210Est. 19851 employees
Revenue 2025
SEK 58K
-38% vs 2024
EBITDA margin
-87.9%
-419% vs 2024
Equity ratio
69.6%
Financial strength
Net profit 2025
SEK -51K
-492% vs 2024
| Revenue | SEK 58K | -38% |
| EBITDA | SEK -51K | -419% |
| Net profit | SEK -51K | -492% |
| Total assets | SEK 467K | -4% |
| Equity | SEK 325K | -14% |
| Employees | 1 | — |
Legal name
Biol Aktiebolag
Org number
5562663053
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
29 oktober 1985
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultverksamhet inom gentetiska bedömningar vid skötsel av naturresurser, konsultverksamhet inom personaladministration, rekryteringsverksamhet till företag och organisationer samt bedriva marknadsföring, utbildning, konsultverksamhet inom administrativ databehandling och statestik analys och därmed förenlig verksamhet.
Address
Skogsslingan 26
Phone
+4687103570
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 45 | 250 | 60 | 93 | 58 |
| Staff expenses | — | −82 | −0 | — | — |
| EBITDA | 10 | 133 | 40 | 16 | −51 |
| Depreciation & amort. | −0 | — | — | −0 | −0 |
| EBIT | 10 | 133 | 40 | 16 | −51 |
| Net financials | — | — | 0 | — | — |
| Profit before tax | 10 | 133 | 40 | 17 | −51 |
| Tax | −0 | −21 | −8 | −4 | −0 |
| Net profit | 10 | 112 | 32 | 13 | −51 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 300 | 487 | 471 | 488 | 467 |
| Equity | 220 | 331 | 363 | 376 | 325 |
| Long-term debt | 0 | — | — | 0 | 0 |
| Short-term debt | 81 | 156 | 108 | 112 | 142 |
| Total debt | 81 | 156 | 108 | 112 | 142 |
EBITDA margin
-87.9%
This company
15.8%
Market median
-656% vs market
20212025
Equity ratio
69.6%
This company
38.2%
Market median
+82% vs market
20212025
Return on equity
-15.7%
This company
18.4%
Market median
-185% vs market
20212025
Net profit margin
-87.9%
This company
8.1%
Market median
-1185% vs market
20212025
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
20212025
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LD | Audit | 2024 |
| Former (2) | ||
GE Auditor Substitute | Auditor Substitute | 2021 – 2022 |
AT Audit | Audit | 2021 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Biol Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gun Elisabeth Holm | Auditor Substitute | 0 companies |
| Arne Tommy Holm | Audit | 0 companies |
| Lars Daniel Andreas Boström | Audit | 0 companies |
| Hans Gunnar Ståhl | Board of Directors | 0 companies |
| Svante Erik Hellsing | Deputy Board Member | 0 companies |